TREATMENT OF CHRONIC TENSION HEADACHE.
D000639:Amitriptyline; D000654:Amobarbital; D001007:Anxiety; D001008:Anxiety Disorders; D035843:Biomedical Research; D002707:Chlordiazepoxide; D003975:Diazepam; D004876:Ergot Alkaloids; D004878:Ergotamine; D006261:Headache; D020773:Headache Disorders; D007099:Imipramine; D008784:Methysergide; D009966:Orphenadrine; D010634:Phenobarbital; D010919:Placebos; D011611:Psychosomatic Medicine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D018781:Tension-Type Headache; D014149:Tranquilizing Agents; D014191:Tranylcypromine; D014268:Trifluoperazine; D014665:Vasodilator Agents
D000639:Amitriptyline; D000654:Amobarbital; D002707:Chlordiazepoxide; D003975:Diazepam; D004876:Ergot Alkaloids; D004878:Ergotamine; D007099:Imipramine; D008784:Methysergide; D009966:Orphenadrine; D010634:Phenobarbital; D010919:Placebos; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014149:Tranquilizing Agents; D014191:Tranylcypromine; D014268:Trifluoperazine; D014665:Vasodilator Agents
AMITRIPTYLINE; AMOBARBITAL; ANXIETY; CHLORDIAZEPOXIDE; CLINICAL RESEARCH; DIAZEPAM; ERGOT ALKALOIDS; ERGOTAMINE; HEADACHE; IMIPRAMINE; METHYSERGIDE; ORPHENADRINE; PHENOBARBITAL; PLACEBOS; PSYCHOSOMATIC MEDICINE; SEROTONIN INHIBITORS; TRANQUILIZING AGENTS; TRANYLCYPROMINE; TRIFLUOPERAZINE; VASODILATOR AGENTS